BR9906373B1 - compostos pirimidinona, composições farmacêuticas contendo os compostos e processos para a preparação dos mesmos. - Google Patents
compostos pirimidinona, composições farmacêuticas contendo os compostos e processos para a preparação dos mesmos.Info
- Publication number
- BR9906373B1 BR9906373B1 BRPI9906373-5A BR9906373A BR9906373B1 BR 9906373 B1 BR9906373 B1 BR 9906373B1 BR 9906373 A BR9906373 A BR 9906373A BR 9906373 B1 BR9906373 B1 BR 9906373B1
- Authority
- BR
- Brazil
- Prior art keywords
- compounds
- preparing
- processes
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- VTGOHKSTWXHQJK-UHFFFAOYSA-N pyrimidin-2-ol Chemical class OC1=NC=CC=N1 VTGOHKSTWXHQJK-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
- C07D239/36—One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019980014821A KR19990081093A (ko) | 1998-04-25 | 1998-04-25 | 피리미디논 화합물, 이를 함유하는 약제학적 조성물 및 이의제조방법 |
| PCT/KR1999/000198 WO1999055681A1 (en) | 1998-04-25 | 1999-04-26 | Pyrimidinone compounds, pharmaceutical compositions containing the compounds and the process for preparing the same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BR9906373A BR9906373A (pt) | 2000-07-11 |
| BR9906373B1 true BR9906373B1 (pt) | 2010-11-16 |
Family
ID=19536698
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI9906373-5A BR9906373B1 (pt) | 1998-04-25 | 1999-04-26 | compostos pirimidinona, composições farmacêuticas contendo os compostos e processos para a preparação dos mesmos. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US6294542B1 (pt) |
| EP (1) | EP0991627B1 (pt) |
| JP (1) | JP3351539B2 (pt) |
| KR (2) | KR19990081093A (pt) |
| CN (1) | CN1195741C (pt) |
| AU (1) | AU753424B2 (pt) |
| BR (1) | BR9906373B1 (pt) |
| CA (1) | CA2295446C (pt) |
| DE (1) | DE69909209T2 (pt) |
| ES (1) | ES2209421T3 (pt) |
| ID (1) | ID29295A (pt) |
| RU (1) | RU2233278C9 (pt) |
| WO (1) | WO1999055681A1 (pt) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100617953B1 (ko) * | 2000-03-23 | 2006-08-30 | 보령제약 주식회사 | 피리미디논 화합물 및 이의 염의 제조방법 |
| DE60132637T2 (de) * | 2001-09-21 | 2009-01-15 | Boryung Pharmaceutical Co., Ltd. | Verfahren zum herstellen von pyrimidionverbindungen und deren pharmazeutisch unbedenklichen salzen |
| KR100521980B1 (ko) * | 2002-10-10 | 2005-10-17 | 보령제약 주식회사 | 피리미디논 화합물 및 이의 염의 삼수화물의 제조 방법 |
| IN2012DN02695A (pt) * | 2010-01-21 | 2015-09-04 | Boryung Pharm | |
| UA110244C2 (en) | 2011-04-12 | 2015-12-10 | Boryung Pharm | Antihypertensive pharmaceutical composition |
| KR101490329B1 (ko) * | 2012-10-12 | 2015-02-04 | 보령제약 주식회사 | 피마살탄 포타슘염의 일수화물 결정, 그 제조방법, 및 그를 포함하는 약제학적 조성물 |
| KR20170006938A (ko) | 2015-07-10 | 2017-01-18 | 보령제약 주식회사 | 만성 신부전의 예방 또는 치료용 조성물 |
| CN105061405A (zh) * | 2015-08-04 | 2015-11-18 | 合肥创新医药技术有限公司 | 非马沙坦钾盐三水合物的制备方法 |
| KR102233673B1 (ko) | 2016-01-27 | 2021-03-30 | 보령제약 주식회사 | 당뇨병성 신장질환의 예방 또는 치료용 약학적 조성물 |
| CN105837514B (zh) * | 2016-01-29 | 2018-09-18 | 北京睿创康泰医药研究院有限公司 | 非马沙坦药物杂质的制备方法 |
| WO2018002673A1 (en) | 2016-07-01 | 2018-01-04 | N4 Pharma Uk Limited | Novel formulations of angiotensin ii receptor antagonists |
| KR101984121B1 (ko) * | 2017-08-21 | 2019-05-30 | 보령제약 주식회사 | 피리미디논 유도체 화합물 및 이의 용도 |
| KR102201396B1 (ko) | 2017-11-30 | 2021-01-11 | 보령제약 주식회사 | 피마살탄을 포함하는 약학적 조성물 |
| KR102078691B1 (ko) | 2017-11-30 | 2020-02-19 | 보령제약 주식회사 | 피마살탄을 포함하는 고체 분산체 |
| KR20200073676A (ko) | 2018-12-14 | 2020-06-24 | 엠에프씨 주식회사 | 발사탄 및 사쿠비트릴을 포함하는 고체 분산체 및 이를 포함하는 약학 조성물 및 이의 제조 방법 |
| CN109485640B (zh) * | 2018-12-24 | 2021-03-26 | 合肥创新医药技术有限公司 | 一种非马沙坦杂质的制备方法 |
| CN112876424B (zh) * | 2019-11-29 | 2023-06-30 | 上海拓界生物医药科技有限公司 | 血管紧张素ii受体及内皮素受体双重拮抗剂 |
| KR102221856B1 (ko) * | 2020-10-12 | 2021-03-02 | 유니셀랩 주식회사 | 신규한 피마살탄 결정형의 다형체 |
| KR20220154987A (ko) | 2021-05-14 | 2022-11-22 | 주식회사 보령 | 허혈성 뇌졸중 또는 일과성 허혈 발작을 갖는 대상체에서의 혈압 조절을 위한 약학적 조성물 |
| KR20220162456A (ko) | 2021-06-01 | 2022-12-08 | 주식회사 보령 | 고혈압을 동반한 당뇨병성 신장질환의 예방 또는 치료용 약학적 조성물 |
| KR20240146734A (ko) | 2023-03-30 | 2024-10-08 | (주) 에프엔지리서치 | 피마살탄의 신규 염 및 이의 제조방법 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5100897A (en) * | 1989-08-28 | 1992-03-31 | Merck & Co., Inc. | Substituted pyrimidinones as angiotensin ii antagonists |
| US5014228A (en) | 1989-09-21 | 1991-05-07 | Schlumberger Technologies, Inc. | Method and apparatus for calibrating linear delay lines |
| TW201738B (pt) * | 1990-03-20 | 1993-03-11 | Sanofi Co | |
| JPH04120072A (ja) * | 1990-09-11 | 1992-04-21 | Meiji Seika Kaisha Ltd | アンジオテンシン２拮抗性ピリミジン誘導体 |
| EP0481614A1 (en) | 1990-10-01 | 1992-04-22 | Merck & Co. Inc. | Substituted pyridopyrimidinones and related heterocycles as angiotensin II antagonists |
| EP0550313A1 (fr) * | 1991-12-30 | 1993-07-07 | Synthelabo | Nouveaux dérivés de 2-(tétrazol-5-yl)-(1,1'-biphényle), leur préparation et leur utilisation comme intermédiaires de synthèse |
| FR2688505B1 (fr) | 1992-03-16 | 1994-05-06 | Synthelabo | Nouveau procede de preparation de 4-pyrimidinones. |
| FR2700543B1 (fr) * | 1993-01-15 | 1995-03-17 | Synthelabo | Sels de dérivés de 4-pyrimidinone, leur préparation et leur application en thérapeutique. |
| JPH07157485A (ja) * | 1993-12-02 | 1995-06-20 | Nkk Corp | 縮合ピリミジノン誘導体及びそれらを含有するアンジオテンシンｉｉ拮抗剤 |
| KR100300566B1 (ko) | 1994-09-17 | 2001-11-22 | 조생현 | 피리미디논유도체와그의제조방법및용도 |
-
1998
- 1998-04-25 KR KR1019980014821A patent/KR19990081093A/ko active Pending
-
1999
- 1999-04-26 EP EP99916058A patent/EP0991627B1/en not_active Expired - Lifetime
- 1999-04-26 CN CNB998006130A patent/CN1195741C/zh not_active Expired - Lifetime
- 1999-04-26 KR KR1019997011636A patent/KR100354654B1/ko not_active Expired - Lifetime
- 1999-04-26 US US09/446,254 patent/US6294542B1/en not_active Expired - Lifetime
- 1999-04-26 ES ES99916058T patent/ES2209421T3/es not_active Expired - Lifetime
- 1999-04-26 BR BRPI9906373-5A patent/BR9906373B1/pt not_active IP Right Cessation
- 1999-04-26 CA CA002295446A patent/CA2295446C/en not_active Expired - Lifetime
- 1999-04-26 ID IDW991643A patent/ID29295A/id unknown
- 1999-04-26 AU AU34438/99A patent/AU753424B2/en not_active Expired
- 1999-04-26 RU RU2000100785/04A patent/RU2233278C9/ru active
- 1999-04-26 DE DE69909209T patent/DE69909209T2/de not_active Expired - Lifetime
- 1999-04-26 JP JP55398899A patent/JP3351539B2/ja not_active Expired - Lifetime
- 1999-04-26 WO PCT/KR1999/000198 patent/WO1999055681A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ES2209421T3 (es) | 2004-06-16 |
| WO1999055681A1 (en) | 1999-11-04 |
| AU3443899A (en) | 1999-11-16 |
| BR9906373A (pt) | 2000-07-11 |
| EP0991627A1 (en) | 2000-04-12 |
| KR19990081093A (ko) | 1999-11-15 |
| KR20010013626A (ko) | 2001-02-26 |
| CA2295446C (en) | 2009-01-06 |
| JP3351539B2 (ja) | 2002-11-25 |
| US6294542B1 (en) | 2001-09-25 |
| DE69909209D1 (de) | 2003-08-07 |
| RU2233278C9 (ru) | 2009-11-27 |
| CN1195741C (zh) | 2005-04-06 |
| DE69909209T2 (de) | 2004-06-03 |
| CN1266428A (zh) | 2000-09-13 |
| AU753424B2 (en) | 2002-10-17 |
| EP0991627B1 (en) | 2003-07-02 |
| RU2233278C2 (ru) | 2004-07-27 |
| KR100354654B1 (ko) | 2002-09-30 |
| ID29295A (id) | 2001-08-16 |
| JP2001508469A (ja) | 2001-06-26 |
| CA2295446A1 (en) | 1999-11-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR9906373B1 (pt) | compostos pirimidinona, composições farmacêuticas contendo os compostos e processos para a preparação dos mesmos. | |
| BR9810802B1 (pt) | composto, composição farmacêutica, e, processo para a preparação de um composto. | |
| BR9912109B1 (pt) | compostos derivados de quinolina, composições farmacêuticas, processo para a manufatura de um composto, e, uso de um composto. | |
| BR9808422B1 (pt) | composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto. | |
| BR9909995B1 (pt) | composto, processo para a preparação de um composto, formulação farmacêutica, e, uso de um composto. | |
| BR9810829B1 (pt) | composto heterocìclico, processo para preparar o mesmo, composição farmacêutica, e, uso de um composto ou de uma composição farmacêutica. | |
| BR9909925B1 (pt) | derivados de quinolina, composições farmacêuticas, e, processo para a fabricação de derivados de quinolina. | |
| EE200000468A (et) | Ühendid, nende kasutamine ja farmatseutiline kompositsioon | |
| BR9800323B1 (pt) | composição lìquida contendo gonadotropina, processo para preparar a mesma, cartucho, e, dispositivo de administração. | |
| BR9801606B1 (pt) | composto, processo para sua preparação, substáncia farmacêutica, uso do composto e processo para a produção de uma substáncia farmacêutica. | |
| BR0008840B1 (pt) | derivados de camptotecina, processos para a sua preparaÇço, composiÇço farmacÊutica que os compreende e uso dos mesmos. | |
| NO20011216L (no) | Azetidinderivater, deres fremstilling og medikamenter inneholdende forbindelsene | |
| BR9805993B1 (pt) | composição farmacêutica de aerossol. | |
| BR9912104B1 (pt) | compostos derivados de quinolina, composições farmacêuticas, e, processo para a manufatura de um composto. | |
| NO20016038D0 (no) | Benzenderivater, fremgangsmåte for deres fremstilling og farmasöytiske preparater inneholdende de samme | |
| BR0001396B1 (pt) | aglomerante, processo para sua preparação, e, utilização do aglomerante. | |
| BR9808037B1 (pt) | mistura de sàlidos, e, processo para a preparaÇço de formulaÇÕes herbicidas. | |
| BR9711311B1 (pt) | derivado de 1,2,3,4-tetrahidroquinolina, composiÇço farmaceutica, uso de um derivado de 1,2,3,4-tetrahidroquinolina, e, processo para a preparaÇço de compostos. | |
| BR9807682B1 (pt) | composto, uso do mesmo, composiÇço farmacÊutica, e, processos para preparar um composto. | |
| IT1311921B1 (it) | Composti farmaceutici. | |
| BRPI9914571B8 (pt) | composto, processo para sua preparação, uso do mesmo, bem como composição farmacêutica. | |
| BR9807988B1 (pt) | processo para a preparaÇço de um composto, e, composto. | |
| DK1118610T3 (da) | Benzensulfonamid-derivater, fremgangsmåde til fremstilling heraf samt farmaceutiske sammensætninger indeholdende derivaterne | |
| MX26368A (es) | Compuestos de beta-lactama,procedimiento e inventarios para su preparacion. | |
| BR9912125B1 (pt) | Benzenossulfoniluréias e - tiouréias 2,5-substituídas, processos para a sua preparação, sua aplicação e preparados farmacêuticos contendo as mesmas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Technical examination (opinion): publication of technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DE INT.CL: C07C 323/25, C07D 239/36, C07D 403/10, C07D 403/04, A61K 31/505, A61P 9/00 Ipc: C07C 323/25 (2008.04), C07D 239/36 (2008.04), C07D |
|
| B06A | Notification to applicant to reply to the report for non-patentability or inadequacy of the application [chapter 6.1 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 16/11/2010, OBSERVADAS AS CONDICOES LEGAIS. |
|
| B21A | Expiry acc. art. 78, item i of ipl- expiry of the term of protection |
Free format text: PATENTE EXTINTA EM 16.11.2020 |